MAMehdi Asadi

Mehdi Asadi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mehdi Asadi has a total of 83 co-authors. Here are the top co-authors by number of shared publications:

  • Mohammad Mahdavi

    Endocrinology and Metabolism Research Center Endocrinology and Metabolism Clinical Sciences Institute Tehran University of Medical Sciences Tehran Iran

    16 shared publications
  • Mina Saeedi

    Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

    11 shared publications
  • Alireza Foroumadi

    Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran

    10 shared publications
  • Abbas Shafiee

    Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran

    7 shared publications
  • Abbas Shafiee

    The University of Queensland Frazer Institute, The University of Queensland, Brisbane, Australia

    4 shared publications
  • Loghman Firoozpour

    Drug design & Development Research Center, Tehran University of Medical Sciences, Tehran, Iran

    4 shared publications

Latest Publications

  • Open Access

    Hyaluronic Acid-Cyclosporine A Nanomicelles for Enhanced Ocular Delivery and Therapeutic Efficacy in Dry Eye Disease

    by Fereshte Khalili, Athar Mahdieh, Farnaz Sadat Mirzazadeh Tekie, Mehdi Asadi, Razieh Sohrabi, Shiva Mozaffari, Rassoul Dinarvand, Mozhgan Rezaei-Kanavi, Hamid Akbari Javar

    Dry eye disease (DED) is a prevalent and multifactorial condition affecting a significant proportion of the global population (~30%), characterized by ocular discomfort, visual disturbances, and chronic inflammation. Cyclosporine A (CyA), a potent immunomodulatory agent, is widely used for DED treatment, but its clinical application is limited by poor water solubility, low ocular bioavailability, rapid clearance, and irritation associated with conventional oil-based formulations. To address these challenges, we developed hyaluronic acid-conjugated CyA (HA-CyA) nanomicelles to enhance ocular retention, targeted cellular uptake, and therapeutic efficacy. HA-CyA was synthesized via a click reaction between propargylated hyaluronic acid and azidated CyA, forming self-assembled nanomicelles in an aqueous solution. The nanomicelles were characterized for particle size, zeta potential, morphology, critical micelle concentration, drug loading, and enzymatic-triggered release. In vitro studies demonstrated high biocompatibility, minimal irritancy, and efficient uptake in human corneal epithelial cells, mediated in part by HA-CD44 interactions. In vivo safety evaluation in rabbits confirmed the absence of ocular toxicity, epithelial defects, or apoptosis. Therapeutic efficacy in atropine-induced DED rabbit models showed that HA-CyA nanomicelles significantly improved tear production, tear film stability, and corneal epithelial integrity, while reducing inflammatory cytokines (TNF-α, IL-1β) compared with commercially available 0.05% CyA eye drops (Restasis®) and 0.15% HA artificial tears (Artipic Advanced®). These findings highlight HA-CyA nanomicelles as a novel, targeted ocular drug delivery platform with prolonged retention, reduced irritation, and effective anti-inflammatory activity for DED management.

  • Targeted delivery of doxorubicin by SP5-52 peptide conjugated exosome nanoparticles into lung tumor: An in vitro and in vivo study

    by Ayda Moradi, Armina Shirangi, Mehdi Asadi, Mehdi Farokhi, Mehdi Gholami, Hossein Aminianfar, Fatemeh Atyabi, Fatemeh Mottaghitalab, Rassoul Dinarvand


  • Recent Developments in Arylation of N-Nucleophiles via Chan-Lam Reaction: Updates from 2012 Onwards

    by Fahimeh Abedinifar, Mohammad Mahdavi, Elham Babazadeh Rezaei, Mehdi Asadi, Bagher Larijani

    ''Chan-Evans-Lam'' (CEL) reaction is the copper-mediated cross-coupling of N-nucleophiles with boronic acids that was independently reported in 1998 by Chan, Evans, and Lam for the first time. This reaction is accomplished at room temperature with a remarkably wide range of nucleophiles. In the recent decade, it has been particularly attractive as a convenient method for constructing the various C– N bonds in organic synthesis. Therefore, a comprehensive survey through all reported process was crucial. In this review, we summarized research progress about N-Arylation, based on the type of N-nucleophile involved in this reaction and catalysts from 2012 onwards.


  • Recent Opportunities and Challenges in Selective C-H Functionalization of Methyl Azaarenes: A Highlight from 2010 to 2020 Studies

    by Fahimeh Abedinifar, Mohammad Mahdavi, Mehdi Asadi, Haleh Hamedifar, Samira Ansari, Bagher Larijani

    Azaarenes are unique scaffolds that are frequently found in pharmaceuticals. Herein we have summarized the recent synthetic available methods in C–H functionalization of methylazaarenes from 2010 to 2020. Multiple approaches involving halogenation, alkylation via different methods, alkenylation, oxidative functionalization, and cyclization of the methylazaarenes will be discussed in this review.


  • Thebaine Derivatives as a New Regulator of Tumor Angiogenesis

    by Elnaz Rezaeiamiri, Mehdi Asadi, Faezeh Sadat Hosseini, Arash Amanlou, Ahmad Reza Dehpour, Massoud Amanlou

    Cancer pain management is mostly done by opioids; however, they have further pharmacological effects apart from analgesia including angiogenesis. In this study, peripherally acting ligands of µ opioid receptor (MOR) were synthesized and evaluated as a tool to investigate peripheral effects of opioids in controlling angiogenesis. For this purpose, the designed compounds were synthesized from thebaine and N-(4-dimethylaminophenyl)maleimide under Diels-Alder and nucleophilic substitution (SN) reactions with different alkyl halides to form quaternary ammonium salts. In silico study conducted by docking these compounds on active (5C1M) and inactive (4DKL) form of MOR. Results of in silico study indicate that all compounds were more likely to be an antagonist of MOR based on their interaction patterns with MOR. For biological assessment, they were tested on human umbilical vein endothelial cells using a proliferation MTT test. Also, these compounds were studied by in vivo hot plate test to examine the ability of compounds to cross the blood-brain barrier (BBB). In biological tests, these compounds showed double-faced results with pro-angiogenic effect in lower doses and anti-angiogenic effect in higher doses. Their pro-angiogenic effect was comparable with VEGF. The in vivo study proved their peripherally acting nature. The contradictory effects of opioids on angiogenesis could be explained by its two different targets including MOR and opioid growth factor receptor. This gives a privilege to opioids for use as an angiogenesis controller. By developing more peripherally acting opioids with minimizing central effects, more research in this area is hoped.

  • Synthesis and Urease Inhibitory Activity of Some 5-Aminomethylene Barbituric/Thiobarbituric Acid Derivatives

    by Mehdi Asadi, Mohammad Mahdavi, Shabnam Mahernia, Zahra Rezaei, Maliheh Safavi, Mina Saeedi, Massoud Amanlou

    In this work, a wide spectrum of 5-aminomethylene barbituric/thiobarbituric acid derivatives was synthesized and evaluated for their Jack bean urease inhibitory activity. Among the synthesized compounds, 5-cyclohexylaminomethylene barbituric acid (3a) showed the most potent activity (IC50 = 25.8 µM), 4 times more potent than hydroxyurea (IC50 = 100.0 µM) and a similar activity to thiourea (IC50 = 22.0 µM), both being as the reference drugs. Also, results from docking studies were in good agreement with those obtained in in vitro assay.


  • Synthesis and Biological Evaluation of 1,3,4-Thiadiazole Linked Phthalimide Derivatives as Anticancer Agents

    by Zahra Rezaei, Setareh Moghimi, Rezvan Javaheri, Mehdi Asadi, Mohammad Mahdavi, Shabnam Shabani, Najmeh Edraki, Omidreza Firuzi, Maliheh Safavi, Mohsen Amini, et al.

    Background: Due to the importance of 1,3,4-thiadiazoles and phthalimides in anticancer agents, a novel series of 1,3,4-thiadiazole-phthalimide system have been synthesized and evaluated in vitro against HT-29 and MCF-7 human cancer cell lines. Methods: The target compounds were prepared through four-step reaction and their cytotoxicities were evaluated by MTT assay. Results: The results showed that 4-nitrobenzoyl moiety containing derivatives are the most potent ones. The morphological evaluation also indicated that these compounds are apoptotic inducers. Conclusion: 4-Nitro-N-(5-((3-(1,3-dioxoisoindolin-2-yl)propyl)thio)-1,3,4-thiadiazol-2-yl)benzamide (8m) exhibits the best inhibitory effect against HT-29 and MCF-7 cell lines with IC50 values of 23.83 and 27.21 μM, respectively.


  • CuBr/Et3N‐Promoted Reactions of 2‐Aminobenzamides and Isothiocyanates: Efficient Synthesis of Novel Quinazolin‐4(3H)‐ones

    by Mohammad Mahdavi, Mehdi Asadi, Mahsa Khoshbakht, Mina Saeedi, Mohammad Bayat, Alireza Foroumadi, Abbas Shafiee

    A series of novel quinazolin‐4(3H)‐one derivatives were efficiently synthesized starting from isatoic anhydride. First, reaction of isatoic anhydride and amines in H2O at room temperature afforded 2‐aminobenzamides. Then, CuBr/Et3N promoted reaction of 2‐aminobenzamides and different aryl isothiocyanates in DMF at 80° afforded the title compounds in good yield.


  • Iodine-Mediated Synthesis of Novel Pyrazole Derivatives

    by Mohammad Mahdavi, Mahsa Khoshbakht, Mina Saeedi, Mehdi Asadi, Mohammad Bayat, Alireza Foroumadi, Abbas Shafiee

    The reaction between N,2-diarylhydrazinecarbothioamide (generated from arylhydrazines and aryl isothiocyanates) and malononitrile in the presence of iodine/triethylamine in N,N-dimethylform­amide at 80 °C afforded novel pyrazoles, 5-amino-1-aryl-3-(arylamino)-1H-pyrazole-4-carbonitriles, in good yields. In this strategy, iodine served as a versatile desulfurizing agent, efficiently promoting the cyclization reaction.


  • Synthesis and Evaluation of Chroman‐4‐One Linked to N‐Benzyl Pyridinium Derivatives as New Acetylcholinesterase Inhibitors

    by Saman Arab, Seyed‐Esmail Sadat‐Ebrahimi, Maryam Mohammadi‐Khanaposhtani, Alireza Moradi, Hamid Nadri, Mohammad Mahdavi, Setareh Moghimi, Mehdi Asadi, Loghman Firoozpour, Morteza Pirali‐Hamedani, et al.

    A novel series of chroman‐4‐one derivatives containing the N‐benzyl pyridinium moiety were designed, synthesized, and evaluated for their acetylcholinesterase (AChE) inhibitory activities. Among the various synthesized compounds, (E)‐1‐(2,3‐dibromobenzyl)‐4‐((7‐ethoxy‐4‐oxochroman‐3‐ylidene)methyl)pyridinium bromide (8l) depicted the most potent anti‐AChE activity (IC50 = 0.048 μM). In addition, the molecular modeling study allowed us to detect possible binding modes that are in full compliance with the observed results through in vitro experiments.